JD Health Financials
| JDHIY Stock | USD 3.81 0.00 0.00% |
JDHIY |
Please note, the imprecision that can be found in JD Health's accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of JD Health International. Check JD Health's Beneish M Score to see the likelihood of JD Health's management manipulating its earnings.
JD Health Stock Summary
JD Health competes with Medical Facilities, Ramsay Health, and Nova Leap. JD Health International Inc., an investment holding company, operates an online healthcare platform in the Peoples Republic of China. JD Health International Inc. is a subsidiary of JD Jiankang Limited. Jd Health is traded on OTC Exchange in the United States.| Instrument | USA Pink Sheet View All |
| Exchange | PINK Exchange |
| Business Address | Jingdong Headquarters, Beijing, |
| Sector | Healthcare |
| Industry | Medical Care Facilities |
| Benchmark | Dow Jones Industrial |
| Website | ir.jdhealth.com |
| Currency | USD - US Dollar |
JD Health Key Financial Ratios
JD Health's financial ratios allow both analysts and investors to convert raw data from JD Health's financial statements into concise, actionable information that can be used to evaluate the performance of JD Health over time and compare it to other companies across industries.| Return On Equity | -0.0097 | |||
| Return On Asset | -0.0099 | |||
| Beta | 0.49 | |||
| Z Score | 75.6 |
JDHIY Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining JD Health's current stock value. Our valuation model uses many indicators to compare JD Health value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across JD Health competition to find correlations between indicators driving JD Health's intrinsic value. More Info.JD Health International is rated second overall in return on equity category among its peers. It also is rated second overall in return on asset category among its peers . Comparative valuation analysis is a catch-all model that can be used if you cannot value JD Health by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for JD Health's Pink Sheet. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.JD Health International Systematic Risk
JD Health's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. JD Health volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
Incorrect Input. Please change your parameters or increase the time horizon required for running this function. The output start index for this execution was zero with a total number of output elements of zero. The Beta measures systematic risk based on how returns on JD Health International correlated with the market. If Beta is less than 0 JD Health generally moves in the opposite direction as compared to the market. If JD Health Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one JD Health International is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of JD Health is generally in the same direction as the market. If Beta > 1 JD Health moves generally in the same direction as, but more than the movement of the benchmark.
JD Health December 22, 2024 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of JD Health help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of JD Health International. We use our internally-developed statistical techniques to arrive at the intrinsic value of JD Health International based on widely used predictive technical indicators. In general, we focus on analyzing JDHIY Pink Sheet price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build JD Health's daily price indicators and compare them against related drivers.
| Information Ratio | 0.1094 | |||
| Maximum Drawdown | 19.06 |
Additional Tools for JDHIY Pink Sheet Analysis
When running JD Health's price analysis, check to measure JD Health's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy JD Health is operating at the current time. Most of JD Health's value examination focuses on studying past and present price action to predict the probability of JD Health's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move JD Health's price. Additionally, you may evaluate how the addition of JD Health to your portfolios can decrease your overall portfolio volatility.